LEP and obesity disorder: Because it is well known that leptin and STAT3 are important players of metabolic diseases, our results suggest that the role of FTO in the liver should be taken into consideration for the understanding of the metabolic regulations and that FTO polymorphisms could contribute to metabolic complications in obesity and diabetes.